SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-017849
Filing Date
2022-05-04
Accepted
2022-05-04 16:09:00
Documents
69
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 GTHX-Q1-2022 10-Q gthx-10q_20220331.htm   iXBRL 10-Q 1602164
2 EX-10.1 gthx-ex101_232.htm EX-10.1 117098
3 EX-31.1 gthx-ex311_210.htm EX-31.1 18141
4 EX-31.2 gthx-ex312_213.htm EX-31.2 17874
5 EX-32.1 gthx-ex321_211.htm EX-32.1 7288
6 EX-32.2 gthx-ex322_212.htm EX-32.2 7284
7 GRAPHIC gl25tih43g1e000001.jpg GRAPHIC 4221
  Complete submission text file 0001564590-22-017849.txt   6623608

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA gthx-20220331.xsd EX-101.SCH 50879
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gthx-20220331_cal.xml EX-101.CAL 36715
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gthx-20220331_def.xml EX-101.DEF 153807
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE gthx-20220331_lab.xml EX-101.LAB 395201
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gthx-20220331_pre.xml EX-101.PRE 288588
63 EXTRACTED XBRL INSTANCE DOCUMENT gthx-10q_20220331_htm.xml XML 1140354
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 22891561
SIC: 2834 Pharmaceutical Preparations